Cargando…
Cefoperazone Sodium Impregnated Polycaprolactone Composite Implant for Osteomyelitis
The use of local antibiotics from a biodegradable implant for chronic osteomyelitis is an attractive alternative. The implant delivers high antibiotic concentration at tissue levels, obliterates dead space, aids bone repair and does not need to be removed. The purpose of this paper is to develop and...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865808/ https://www.ncbi.nlm.nih.gov/pubmed/20502542 http://dx.doi.org/10.4103/0250-474X.57285 |
_version_ | 1782180876259426304 |
---|---|
author | Anand, A. Pundir, R. Pandian, C. S. Saraf, S. Gupta, H. |
author_facet | Anand, A. Pundir, R. Pandian, C. S. Saraf, S. Gupta, H. |
author_sort | Anand, A. |
collection | PubMed |
description | The use of local antibiotics from a biodegradable implant for chronic osteomyelitis is an attractive alternative. The implant delivers high antibiotic concentration at tissue levels, obliterates dead space, aids bone repair and does not need to be removed. The purpose of this paper is to develop and evaluate a calcium sulphate and polycaprolactone based composite biodegradable implantable delivery system of cefoperazone sodium. Implants were prepared by modified fabrication technique to avoid solvent use. Interaction studies were carried out to check any incompatibility between ingredients. Prepared implants were evaluated for various in vitro parameters like dimensions, hardness, tensile strength, drug release profile and sterility. Morphological changes in pellet before and after drug release were evaluated by scanning electron microscopy. The pellet were also tested for microbiological efficacy and compared with plain drug solution in different concentrations. Developed pellets are regular in shape and size with good tensile strength. The release profile displayed drug levels above MIC continuously up to 2 months. Wide zone of inhibition by pellet against Staph. aureus as compared to drug solution proves its efficacy in treatment of osteomyelitis. |
format | Text |
id | pubmed-2865808 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Medknow Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-28658082010-05-25 Cefoperazone Sodium Impregnated Polycaprolactone Composite Implant for Osteomyelitis Anand, A. Pundir, R. Pandian, C. S. Saraf, S. Gupta, H. Indian J Pharm Sci Research Paper The use of local antibiotics from a biodegradable implant for chronic osteomyelitis is an attractive alternative. The implant delivers high antibiotic concentration at tissue levels, obliterates dead space, aids bone repair and does not need to be removed. The purpose of this paper is to develop and evaluate a calcium sulphate and polycaprolactone based composite biodegradable implantable delivery system of cefoperazone sodium. Implants were prepared by modified fabrication technique to avoid solvent use. Interaction studies were carried out to check any incompatibility between ingredients. Prepared implants were evaluated for various in vitro parameters like dimensions, hardness, tensile strength, drug release profile and sterility. Morphological changes in pellet before and after drug release were evaluated by scanning electron microscopy. The pellet were also tested for microbiological efficacy and compared with plain drug solution in different concentrations. Developed pellets are regular in shape and size with good tensile strength. The release profile displayed drug levels above MIC continuously up to 2 months. Wide zone of inhibition by pellet against Staph. aureus as compared to drug solution proves its efficacy in treatment of osteomyelitis. Medknow Publications 2009 /pmc/articles/PMC2865808/ /pubmed/20502542 http://dx.doi.org/10.4103/0250-474X.57285 Text en © Indian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Anand, A. Pundir, R. Pandian, C. S. Saraf, S. Gupta, H. Cefoperazone Sodium Impregnated Polycaprolactone Composite Implant for Osteomyelitis |
title | Cefoperazone Sodium Impregnated Polycaprolactone Composite Implant for Osteomyelitis |
title_full | Cefoperazone Sodium Impregnated Polycaprolactone Composite Implant for Osteomyelitis |
title_fullStr | Cefoperazone Sodium Impregnated Polycaprolactone Composite Implant for Osteomyelitis |
title_full_unstemmed | Cefoperazone Sodium Impregnated Polycaprolactone Composite Implant for Osteomyelitis |
title_short | Cefoperazone Sodium Impregnated Polycaprolactone Composite Implant for Osteomyelitis |
title_sort | cefoperazone sodium impregnated polycaprolactone composite implant for osteomyelitis |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865808/ https://www.ncbi.nlm.nih.gov/pubmed/20502542 http://dx.doi.org/10.4103/0250-474X.57285 |
work_keys_str_mv | AT ananda cefoperazonesodiumimpregnatedpolycaprolactonecompositeimplantforosteomyelitis AT pundirr cefoperazonesodiumimpregnatedpolycaprolactonecompositeimplantforosteomyelitis AT pandiancs cefoperazonesodiumimpregnatedpolycaprolactonecompositeimplantforosteomyelitis AT sarafs cefoperazonesodiumimpregnatedpolycaprolactonecompositeimplantforosteomyelitis AT guptah cefoperazonesodiumimpregnatedpolycaprolactonecompositeimplantforosteomyelitis |